Quarterly ResultNov 10, 2026, 05:31 PM
Yubo International Biotech Ltd. Q3 2026 Net Loss $203,726
AI Summary
Yubo International Biotech Ltd. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The company reported a net loss of $203,726 for the third quarter of 2026, an improvement from the $310,152 net loss in the same quarter of 2025. However, for the nine-month period, the net loss widened to $767,473 from $902,288 in the prior year. The company's total assets decreased, while total liabilities and shareholders' deficit increased, indicating a challenging financial position.
Key Highlights
- Yubo International Biotech Ltd reported a net loss of $203,726 for Q3 2026, compared to a net loss of $310,152 in Q3 2025.
- For the nine months ended September 30, 2026, the net loss was $767,473, compared to $902,288 for the same period in 2025.
- Total assets decreased to $651,391 as of September 30, 2026, from $847,094 as of December 31, 2025.
- Total liabilities increased to $3,549,427 as of September 30, 2026, from $2,791,297 as of December 31, 2025.
- Shareholders' deficit increased to $2,898,036 as of September 30, 2026, from $1,944,203 as of December 31, 2025.
Price Impact
More from YBGJ